Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling

Executive Vice President of Commercial Operations Kevin Young -- the company's top drug salesman -- announced his retirement on Monday night.

http://www.thestreet.com/story/12212267/1/gilead-sales-chief-retires-amidst-key-hep-c-drug-launch-massive-insider-selling.html